Optical Coherence Tomography Grading Reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials
- 31 December 2012
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 119 (12), 2549-2557
- https://doi.org/10.1016/j.ophtha.2012.06.040
Abstract
No abstract availableKeywords
Funding Information
- Heed Ophthalmic Foundation
This publication has 34 references indexed in Scilit:
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2011
- A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular DegenerationOphthalmology, 2010
- Evaluation of optical coherence tomography findings in age-related macular degeneration: a reproducibility study of two independent reading centresBritish Journal of Ophthalmology, 2010
- Spectral-Domain Optical Coherence Tomography for Monitoring Epiretinal Membrane SurgeryOphthalmology, 2010
- The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study System for Evaluation of Optical Coherence TomogramsJAMA Ophthalmology, 2009
- Comparison of Clinically Relevant Findings from High-Speed Fourier-Domain and Conventional Time-Domain Optical Coherence TomographyAmerican Journal of Ophthalmology, 2009
- Comparison of Optical Coherence Tomography in Diabetic Macular Edema, with and without Reading Center Manual Grading from a Clinical Trials PerspectiveInvestigative Opthalmology & Visual Science, 2009
- Angiographic and Optical Coherence Tomographic Results of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular DegenerationOphthalmology, 2007
- High-Definition and 3-dimensional Imaging of Macular Pathologies with High-speed Ultrahigh-Resolution Optical Coherence TomographyOphthalmology, 2006
- High agreement but low Kappa: I. the problems of two paradoxesJournal of Clinical Epidemiology, 1990